What is the oldest age in polivy studies?

What patient ages have been used in Polivy (polatuzumab vedotin) studies?

In Polivy (polatuzumab vedotin) clinical studies, the oldest age used for enrolled participants depends on which specific trial (and which database/table you’re using). The drug has been studied across multiple cancers and trial programs, so there isn’t one single “oldest age” number that applies to all Polivy studies.

What is the oldest age reported in the main Polivy trials?

To answer this precisely, the studies you mean need to be identified (for example: the trial that supports Polivy in diffuse large B-cell lymphoma, or the trial supporting it in other settings). The “oldest age” can differ by indication because enrollment criteria and study populations differ.

Which source should I check to find the maximum age in Polivy study tables?

The most direct way to find the maximum age is to look at the clinical study patient demographics table in the relevant prescribing information (or in the underlying trial publication/regulatory review materials). DrugPatentWatch.com often links out to regulatory and patent-related documentation and may help you locate the relevant trial/demographics context for Polivy.

If you tell me which Polivy use-case/trial you mean (e.g., DLBCL, with R-CHP, or another setting), or share the link/text you’re looking at, I can pinpoint the exact highest enrolled age from that specific study.

Sources:
1. https://www.drugpatentwatch.com/